The results revealed that all mice in the YB1 group were alive 3 weeks after YB1 injection while all mice in the SL7207 group died within 11 days of the SL7207 injection. YB1 group were alive 3 weeks after YB1 injection while all mice in the SL7207 group died within 11 days of the SL7207 injection. The body weight decreased by ~9% on Phenytoin sodium (Dilantin) day 1 after YB1 injection and but subsequently recovered. Liver tumor growth and metastases were significantly inhibited following YB1 treatment. By contrast to the control group, a large number of Gr1-positive cells were detected on days 1 to 21 following YB1 treatment. Furthermore, YB1 also effectively invaded tumor cells and induced tumor cell apoptosis and death. In conclusion, YB1 suppressed liver tumor growth and metastasis in a nude mice liver tumor model. The potential mechanism may be through enhancing innate immune response and inducing tumor cell apoptosis and cell death. Keywords: YB1, hepatocellular carcinoma, tumor growth, metastasis, apoptosis, immune response == Introduction == Hepatocellular carcinoma (HCC) is one of the most malignant tumors worldwide (1). Surgical therapies including hepatectomy and liver transplantation are first-line treatments for HCC patients, but the unlikelihood of early diagnosis and the high incidence of tumor recurrence and metastasis following surgery remain major obstacles (2, 3). Non-surgical treatments including radiofrequency ablation, alcohol injection and transcatheter arterial chemoembolization have made great advances in recent years. However , they have substantial limitations, including toxicity, insufficient tissue penetration and poor tumor targeting, which together often result in incomplete destruction of the tumors (46). Therefore , the development of novel adjuvant therapies for the suppression of liver cancer growth and metastasis is essential. Researchers are now turning to bacterial treatments and consider this a promising new strategy in cancer therapy. Certain bacterial species includingSalmonella, ClostridiaandBifidobacteriahave been observed to preferentially replicate and accumulate in tumors (711). Through observations and research over the past century, bacteria has been noted to affect the tumor in the following ways (12, 13): i) as a tumoricidal agent; ii) as a vector for gene therapy; iii) as toxins for cancer treatment; iv) as bacterial spores; and v) as an immunotherapeutic agent. However , major problems with using bacteria as anti-cancer agents include the systemic infection of bacteria (7, 14) and the inability to completely eradicate cancer cells. Wild-type bacteria includingSalmonellamay induce severe infection, which may result in septic shock and high lethality (7). Therefore , researchers use autotrophic mutations to attenuate the virulence ofSalmonellain diverse ways (15). Previously, we engineered YB1, which was derived from the attenuatedSalmonellastrain SL7207 (1621). Although SL7207 hasaroAand other pathogenic gene mutations, it is lethal for nude mice if administrated intravenously. In YB1, the essential Phenytoin sodium (Dilantin) geneasdwas engineered to be controlled by the hypoxic promoter Pept and the antisense aerobic promoter SodA. Theasdgene is a key enzyme in the synthesis Phenytoin sodium (Dilantin) of diaminopimelic acid (DAP), which is an essential component for the gram-negative bacteria cell wall. A deficiency ofasdexpression or shortage of extrinsic DAP supply in the environment leads to bacterial lysis in a short period of time. Therefore , without additional DAP, YB1 only survives under hypoxic conditions Phenytoin sodium (Dilantin) ( <0. 5% oxygen) (20). However , the normal capabilities of YB1 are not infected. In a naughty mouse breasts tumor version, YB1 was rapidly taken out from natural organs because of their normoxia circumstances. However , in tumors, YB1 accumulated inside hypoxic place and induced tumor regression (20). From this study, we all explored the actual anti-cancer a result Mouse monoclonal to E7 of YB1 in HCC employing an orthotopic liver tumour animal version with far away metastatic potential. We found that hard working liver tumor expansion was drastically inhibited pursuing YB1 treatment. Furthermore, YB1 also drastically decreased the incidence of lung metastasis. These benefits indicate that YB1 incorporates a great prospects for liver cancer tumor therapy also it gives a new model to examine the components underlying the high efficiency of microbe suppression of liver cancer tumor growth and metastasis. == Materials and methods == == == == Orthotopic nude rats liver tumour model == The orthotopic liver tumour model began in naughty mice (male, 46 several weeks old, 1824 g) extracted from the Lab Doggie Unit within the University of Hong Kong (22). MHCC-97L skin cells (6105; Hard working liver Cancer Commence, Fudan School, China) in 0. one particular ml way of life medium had been injected subcutaneously into the proper flank within the nude rats. Once the subcutaneous tumors come to 0. main to Phenytoin sodium (Dilantin) 1 centimeter in size, they were taken away and trim into cube 1 to 2 mm3in size, which are subsequently incorporated into the kept liver.